Insider screener

Period: 12 months Plan: Scheduled (10b5-1) × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

23,607 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

23,607 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

23,607 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

23,607 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
23,607 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
23,607 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

23,607 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
3 Dec 2025
Eduard Grabscheid Chief Financial Officer
Sold on a plan
$209.09K 3,439 at 60.80
2.6%
Planned (10b5-1)
3 Dec 2025
Tonya Stevens CVP, Chief Accounting Officer
Sold on a plan
$194.29K 2,593 at 74.93
3.5%
Planned (10b5-1)
3 Dec 2025
John Sheldon Peters Chief Insurance Officer
Sold on a plan
$193.01K 2,667 at 72.37
3.5%
Planned (10b5-1)
3 Dec 2025
Brendan Mulligan General Counsel and Secretary
Sold on a plan 2×
$161.11K 4,392 at 36.68
0.5%
Planned (10b5-1)
3 Dec 2025
Jonathan Biller EVP and Chief Legal Officer
Sold on a plan
$155.80K 347 at 449.00
2.2%
Planned (10b5-1)
3 Dec 2025
Alane P Barnes Chief Legal Officer
Sold on a plan
$151.24K 19,770 at 7.65
5.4%
Planned (10b5-1)
3 Dec 2025
David Lawee Director
Sold on a plan
$148.32K 6,578 at 22.55
5.9%
Planned (10b5-1)
3 Dec 2025
Jack Bendheim President and CEO · indirect
Sold on a plan
$143.51K 3,520 at 40.77
6.2%
Planned (10b5-1)
3 Dec 2025
Lori C. Locke Chief Accounting Officer
Sold on a plan
$120.90K 5,000 at 24.18
3.8%
Planned (10b5-1)
3 Dec 2025
Craig C. Hopkinson EVP R&D, Chief Medical Officer
Sold on a plan
$112.45K 3,748 at 30.00
5.4%
Planned (10b5-1)
3 Dec 2025
Steven Yi See Remarks
Sold on a plan 2×
$107.00K 8,000 at 13.37
0.3%
Planned (10b5-1)
3 Dec 2025
Leonard Livschitz Chief Executive Officer
Sold on a plan
$90.00K 10,000 at 9.00
0.4%
Planned (10b5-1)
3 Dec 2025
Eugene Nonko Director · indirect
Sold on a plan 2×
$89.64K 6,700 at 13.38
0.4%
Planned (10b5-1)
3 Dec 2025
David Foehr Senior VP, Finance and PAO
Sold on a plan 3×
$88.61K 5,265 at 16.83
21.4%
Planned (10b5-1)
3 Dec 2025
Tyler Herb Chief Accounting Officer
Sold on a plan 2×
$84.54K 2,310 at 36.60
1.1%
Planned (10b5-1)
3 Dec 2025
David Sherry Chief Financial Officer
Sold on a plan 4×
$77.29K 833 at 92.79
0.2%
Planned (10b5-1)
3 Dec 2025
Laura Olle Director
Sold on a plan
$75.12K 1,423 at 52.79
3.9%
Planned (10b5-1)
3 Dec 2025
Eugene Nonko Director
Sold on a plan 2×
$72.23K 5,400 at 13.38
0.5%
Planned (10b5-1)
3 Dec 2025
Erik C Blachford Director
Sold on a plan
$69.97K 965 at 72.51
2.8%
Planned (10b5-1)
3 Dec 2025
Donald F. Coleman Chief Operating Officer
Sold on a plan
$69.35K 1,541 at 45.00
0.3%
Planned (10b5-1)
3 Dec 2025
Emma Reeve Director
Sold on a plan
$57.63K 733 at 78.62
9.9%
Planned (10b5-1)
3 Dec 2025
Alexander Cumbo President and CEO
Sold on a plan
$55.23K 10,808 at 5.11
11.7%
Planned (10b5-1)
3 Dec 2025
Sanjay Munshi Chief Operating Officer
Sold on a plan
$54.46K 2,000 at 27.23
24.2%
Planned (10b5-1)
3 Dec 2025
Matthew Rizik Director
Sold on a plan
$49.95K 2,500 at 19.98
0.3%
Planned (10b5-1)
3 Dec 2025
Ansbert Gadicke Former 10% Owner · indirect also filed by MPM BioVentures 2014, L.P.
Sold on a plan
$49.79K 57,225 at 0.87
1.2%
Planned (10b5-1)
3 Dec 2025
Preto Joseph Del CFO and Treasurer
Sold on a plan
$45.99K 4,500 at 10.22
1.9%
Planned (10b5-1)
3 Dec 2025
Ned S Holmes Director · indirect
Sold on a plan 4×
$42.05K 600 at 70.08
1.4%
Planned (10b5-1)
3 Dec 2025
Liberman A Jeffery President and COO · indirect
Sold on a plan
$40.08K 14,405 at 2.78
4.5%
Planned (10b5-1)
3 Dec 2025
Jennifer H Mak Chief Accounting Officer
Sold on a plan
$39.72K 74 at 536.75
0.5%
Planned (10b5-1)
3 Dec 2025
Ned S Holmes Director
Sold on a plan 2×
$35.05K 500 at 70.10
0.6%
Planned (10b5-1)
3 Dec 2025
Luke Evnin Director · indirect
Sold on a plan
$31.95K 36,726 at 0.87
1.2%
Planned (10b5-1)
3 Dec 2025
K Charles Janac President and CEO
Sold on a plan
$31.94K 2,058 at 15.52
1.3%
Planned (10b5-1)
3 Dec 2025
Fernando M. Rodrigues President of BetterHelp
Sold on a plan
$31.48K 4,209 at 7.48
100%
Sold half or more
3 Dec 2025
Carmen Amara Chief People Officer
Sold on a plan
$30.00K 1,000 at 30.00
1.3%
Planned (10b5-1)
3 Dec 2025
Sold on a plan
$26.25K 25,000 at 1.05
20.0%
Planned (10b5-1)
3 Dec 2025
David T Howton Chief Operating Officer
Sold on a plan
$25.20K 4,932 at 5.11
13.0%
Planned (10b5-1)
3 Dec 2025
Jessie Hanrahan Chief Regulatory Officer
Sold on a plan
$22.91K 4,483 at 5.11
14.4%
Planned (10b5-1)
3 Dec 2025
Dan Paterson President and CEO
Sold on a plan
$20.00K 2,000 at 10.00
0.5%
Planned (10b5-1)
3 Dec 2025
Randall Moreadith Chief Scientific Officer
Sold on a plan
$17.62K 5,000 at 3.52
100%
Sold half or more
3 Dec 2025
Sold on a plan
$17.47K 241 at 72.51
49.9%
Planned (10b5-1)
3 Dec 2025
Paul Herzich Chief Technology Officer
Sold on a plan
$13.80K 2,701 at 5.11
9.2%
Planned (10b5-1)
3 Dec 2025
Sold on a plan
$12.06K 5,603 at 2.15
2.0%
Planned (10b5-1)
3 Dec 2025
Nicholas Tatum Chief Accounting Officer
Sold on a plan
$9.49K 596 at 15.93
0.9%
Planned (10b5-1)
3 Dec 2025
Paul L Alpern VP and General Counsel
Sold on a plan
$6.29K 425 at 14.79
0.6%
Planned (10b5-1)
3 Dec 2025
Gary H Tauss Director
Sold on a plan
$5.98K 1,000 at 5.98
5.2%
Planned (10b5-1)
3 Dec 2025
Laurent R Moll Chief Operating Officer
Sold on a plan
$2.99K 202 at 14.79
0.1%
Planned (10b5-1)
3 Dec 2025
Matthew Nordby Director
Sold on a plan
$2.38K 1,000 at 2.38
0.9%
Planned (10b5-1)
3 Dec 2025
Linda Burkly EVP, Chief Scientific Officer
Sold on a plan
$1.54K 713 at 2.15
1.0%
Planned (10b5-1)
3 Dec 2025
Amy Parison SVP, Chief Financial Officer
Sold on a plan
$992.58 461 at 2.15
2.8%
Planned (10b5-1)
Showing 21,901–21,950 of 23,607. ← Newer Page 439 of 473 Older →